FDAnews
www.fdanews.com/articles/178448-advanced-accelerator-applications-gets-positive-ema-opinion-on-application-for-somakit-toc

Advanced Accelerator Applications Gets Positive EMA Opinion on Application for SomaKit TOC

September 16, 2016

EMA has issued a positive opinion on the marketing authorization application for SomaKit TOC 40µg kit.

This device kit was developed for preparation of gallium-edotreotide solution for injection for Positron Emission Tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or expected gastroenteropancreatic neuroendocrine tumors (GEP-NET) to identify primary tumors and their metastases.

The European Commission’s official marketing authorization is expected soon. — Cynthia Jessup

View today's stories